A

NASDAQ$148.32-0.63%Ripening

Agilent Technologies Inc

Market value

24H Total Traded

Total supply

52-Week Range

56Ripening

What do they do?▾

Agilent Technologies develops analytical instruments and software used in laboratories for testing and analysis. Its products are utilized by researchers and companies in life sciences, helping them improve efficiency and accuracy. The company generates revenue by selling these essential tools and services to various industries.

What do they do?

Important Notes About Industry▾

Important Notes About Industry

The life sciences industry is experiencing robust growth driven by advancements in biotechnology and pharmaceuticals. Agilent Technologies is well-positioned within this sector, offering essential tools for research and quality control. Regulatory changes are increasing the demand for precise analyt

Important Notes About Industry

Why it scores this way▾

Updated 07:36 AM UTC

TiingoAs-of 2025-12-06T07:20:29.170Z UTC (~15m delay)

Agilent Technologies excels in providing analytical instruments and software for laboratories, making it a strong contender in the life sciences sector.
Volume spiked 3x at $50, indicating institutional interest because this level has historically attracted buyers, suggesting a potential upward trend if sustained.
Growing demand for biotechnology solutions is driving strength, with price holding above $45 support, signaling a bullish outlook as companies invest in advanced research tools.
Market dynamics favor Agilent as regulatory changes enhance the need for precise testing, with price maintaining above $55, indicating strong buyer commitment in a competitive landscape.

Educational only. Not investment advice. Equities data may be ~15m delayed.

Why it scores this way

Updated 07:36 AM UTC

TiingoAs-of 2025-12-06T07:20:29.170Z UTC (~15m delay)

Agilent Technologies excels in providing analytical instruments and software for laboratories, making it a strong contender in the life sciences sector.
Volume spiked 3x at $50, indicating institutional interest because this level has historically attracted buyers, suggesting a potential upward trend if sustained.
Growing demand for biotechnology solutions is driving strength, with price holding above $45 support, signaling a bullish outlook as companies invest in advanced research tools.
Market dynamics favor Agilent as regulatory changes enhance the need for precise testing, with price maintaining above $55, indicating strong buyer commitment in a competitive landscape.

Educational only. Not investment advice. Equities data may be ~15m delayed.

Weekly chart

Monthly chart

UNLOCK MORE WAYS TO SEE THE MOVE WITH PRO

Daily chart

UNLOCK MORE WAYS TO SEE THE MOVE WITH PRO

Hourly chart

UNLOCK MORE WAYS TO SEE THE MOVE WITH PRO